ADIPOQ and essential hypertension: High circulating levels of adiponectin have also been reported as predictors of incident cardiovascular and renal events in treated hypertensive patients [25] and to be released upon blockade of the renin-angiotensin system in patients with essential hypertension to improve insulin sensitivity [26].